0001752724-21-192342.txt : 20210830 0001752724-21-192342.hdr.sgml : 20210830 20210830171048 ACCESSION NUMBER: 0001752724-21-192342 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210830 PERIOD START: 20210630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Highland Funds I CENTRAL INDEX KEY: 0001354917 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-21866 FILM NUMBER: 211224429 BUSINESS ADDRESS: STREET 1: 2515 MCKINNEY AVENUE STREET 2: SUITE 1100 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 833-697-6246 MAIL ADDRESS: STREET 1: 2515 MCKINNEY AVENUE STREET 2: SUITE 1100 CITY: DALLAS STATE: TX ZIP: 75201 FORMER COMPANY: FORMER CONFORMED NAME: PYXIS FUNDS I DATE OF NAME CHANGE: 20120109 FORMER COMPANY: FORMER CONFORMED NAME: Highland Funds I DATE OF NAME CHANGE: 20060302 0001354917 S000021242 Highland Healthcare Opportunities Fund C000060521 Class A HHCAX C000060522 Class C HHCCX C000060523 Class Z HHCZX NPORT-P 1 primary_doc.xml NPORT-P false 0001354917 XXXXXXXX S000021242 C000060523 C000060521 C000060522 Highland Funds I 811-21866 0001354917 549300D4RVXJJ0JOL180 200 CRESCENT COURT SUITE 700 DALLAS 75201 9726284100 Highland Healthcare Opportunities Fund S000021242 549300G5T2BUVOTD6774 2021-06-30 2021-06-30 N 27405418.92 3015455.02 24389963.90 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 UST Twist Bioscience Corp 549300T23BL59LCOH584 90184D100 7500.00000000 NS USD 999375.00000000 4.097484539532 Long EC US N 1 N N N HOOKIPA Pharma Inc N/A 43906K100 110000.00000000 NS USD 1007600.00000000 4.131207426674 Long EC US N 1 N N N AMICUS THERAPEUTICS, INC. 549300MRD1SMUTNBPQ53 03152W109 48800.00000000 NS USD 470432.00000000 1.928793342740 Long EC US N 1 N N N BIOMARIN PHARMACEUTICAL INC. NSLL8ITTRR0J5HEMR848 09061G101 5000.00000000 NS USD 417200.00000000 1.710539637166 Long EC US N 1 N N N UNITEDHEALTH GROUP INCORPORATED 549300GHBMY8T5GXDE41 91324P102 1712.00000000 NS USD 685553.28000000 2.810800716273 Long EC US N 1 N N N GALAPAGOS NV 549300QKJ78IY0IOV655 36315X101 14000.00000000 NS USD 964460.00000000 3.954331396119 Long EC US N 1 N N N NextCure Inc 549300Y5PR6RJR1STI24 65343E108 234708.00000000 NS USD 1884705.24000000 7.727380195097 Long EC US N 1 N N N PARATEK PHARMACEUTICALS, INC. 5493007V5QDIWECEYV79 699374302 150000.00000000 NS USD 1023000.00000000 4.194348151536 Long EC US N 1 N N N SCYNEXIS INC C EX 21JUN21 N/A N/A 25500.00000000 NC USD 0.00000000 0.000000 N/A DE US N 3 SCYNEXIS INC C EX 21JUN21 N/A Call Purchased N/A N/A 25500.00000000 5.00000000 USD 2022-06-21 XXXX 0.00000000 N N N Berkeley Lights Inc 549300LTLRE4N65CD358 084310101 30000.00000000 NS USD 1344300.00000000 5.511693274789 Long EC US N 1 N N NEKTAR THERAPEUTICS 5299005I24806IOIYE03 640268108 45000.00000000 NS USD 772200.00000000 3.166056346643 Long EC US N 1 N N N INSMED INCORPORATED 529900Q55QAG41CCAC11 457669307 12000.00000000 NS USD 341520.00000000 1.400248074987 Long EC US N 1 N N N ABBVIE INC. FR5LCKFTG8054YNNRU85 00287Y109 15000.00000000 NS USD 1689600.00000000 6.927439527698 Long EC US N 1 N N N Singular Genomics Systems Inc N/A 82933R100 47342.00000000 NS USD 1300958.16000000 5.333989690735 Long EC US N 1 N N N EYEPOINT PHARMACEUTICALS, INC. 549300QE1RU34T50MR69 30233G209 0.30000000 NS USD 2.70000000 0.000011070127 Long EC US N 1 N N N ORGANON & CO. 549300AMCKY57OK2CO56 68622V106 45000.00000000 NS USD 1361700.00000000 5.583034093789 Long EC US N 1 N N N Uniqure NV N/A N90064101 70000.00000000 NS USD 2156000.00000000 8.839701480656 Long EC US N 1 N N N GEMPHIRE THERAPEUTICS INC WTS CALL EXP 15MAR22 N/A N/A 4751.88000000 NC USD 1.04000000 0.000004264048 N/A DE US N 3 GEMPHIRE THERAPEUTICS INC WTS CALL EXP 15MAR22 N/A Call Purchased N/A N/A 4751.88000000 260.00000000 USD 2022-03-15 XXXX 1.04000000 N N N AMINO INC SERIES C N/A 931FZP909 608695.00000000 NS USD 0.00000000 0.000000 Long EP US N 3 N N N STEADYMED LTD CVR N/A 963FHD907 54749.00000000 NS USD 0.00000000 0.000000 Long EC US N 3 N N N HUMANA INC. 529900YLDW34GJAO4J06 444859102 2000.00000000 NS USD 885440.00000000 3.630345676731 Long EC US N 1 N N N ABEONA THERAPEUTICS INC. 54930002Z8PIJRCB4576 00289Y107 500000.00000000 NS USD 780000.00000000 3.198036713781 Long EC US N 1 N N N ATAI Life Sciences NV 391200Z8UWPJSNBNCA11 N0731H103 90000.00000000 NS USD 1665000.00000000 6.826578369802 Long EC US N 1 N N N Convey Holding Parent Inc N/A 21258C108 100000.00000000 NS USD 1138000.00000000 4.665853564465 Long EC US N 1 N N N Minerva Neurosciences Inc 54930017PANCHC5LYH79 603380106 320203.00000000 NS USD 742870.96000000 3.045805902156 Long EC US N 1 N N Vor Biopharma Inc N/A 929033108 50000.00000000 NS USD 932500.00000000 3.823293891796 Long EC US N 1 N N N EXELIXIS, INC. 254900PJQB59O2O95R37 30161Q104 50000.00000000 NS USD 911000.00000000 3.735142879813 Long EC US N 1 N N N Vyne Therapeutics Inc N/A 92941V209 0.25000000 NS USD 0.88000000 0.000003608041 Long EC US N 1 N N N ANTHEM, INC. 8MYN82XMYQH89CTMTH67 036752103 969.00000000 NS USD 369964.20000000 1.516870633826 Long EC US N 1 N N N Dreyfus Treasury Obligations Cash Management; Institutional Shares N/A 261908107 5630421.67000000 PA USD 5630421.67000000 23.08499386503 Long STIV US N 1 N N N 2021-06-30 Highland Funds I Jason Post Jason Post CCO